Showing results (1231-1240 of 1,368) with videos related to

Sort By:
Pageof 137
Stem Cell Research & Therapy|January 9, 2019
Clonal derivation of white and brown adipocyte progenitor cell lines from human pluripotent stem cellsMichael D West, Ching-Fang Chang, Dana Larocca, et al.
Cell Host & Microbe|November 1, 2019
Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR<sup>-/-</sup> MiceRafael A Larocca, Erica A Mendes, Peter Abbink, et al.
Haematologica|July 28, 2018
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)Sara Bringhen, Alberto Milan, Claudio Ferri, et al.
Haematologica|April 23, 2026
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myelomaMichela Cumerlato, Monica Maccagno, María Labrador, et al.
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
Scientific Reports|February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signalingA Romano, N L Parrinello, V Simeon, et al.
Plos One|April 29, 2015
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell BiologyCourtney M Tate, Jacquelyn Mc Entire, Roberto Pallini, et al.
Neurology|October 24, 2019
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial dataMyla D Goldman, Nicholas G LaRocca, Richard A Rudick, et al.
Science (New York, N.Y.)|January 17, 2015
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infectionPablo Penaloza-MacMaster, Daniel L Barber, E John Wherry, et al.
Blood|August 20, 2013
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label studyAlessandra Larocca, Vittorio Montefusco, Sara Bringhen, et al.
Pageof 137